Stay updated on Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial

Sign up to get notified when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A banner was added announcing NIH’s transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision label changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:21:48.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.3%
    Check dated 2026-10-06T22:25:15.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, blocking access to the study record. Linked documents and related content appear removed or unavailable on this page.
    Difference
    18%
    Check dated 2026-09-23T00:17:20.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A new revision tag Revision: v3.7.0 was added to the page. The changes also removed several related-topic items (Multiple myeloma, related topics:, MedlinePlus Genetics) and the older Revision: v3.6.6.
    Difference
    0.1%
    Check dated 2026-09-15T23:40:46.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6 on the page, indicating a minor platform release. No changes appear to affect study content or user-facing features.
    Difference
    0.0%
    Check dated 2026-09-01T19:57:13.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The changes add funding context (NIH grant/contract), explicitly reference Multiple Myeloma in related topics, and include a MedlinePlus Genetics related topics link, providing extra background information without altering the study details.
    Difference
    0.1%
    Check dated 2026-08-25T21:43:49.000Z thumbnail image

Stay in the know with updates to Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.